Concepts (158)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Azithromycin | 1 | 2015 | 201 | 0.460 |
Why?
|
Pseudomonas Infections | 1 | 2015 | 622 | 0.370 |
Why?
|
Long QT Syndrome | 1 | 2015 | 474 | 0.360 |
Why?
|
Pancreatic Neoplasms | 6 | 2024 | 5444 | 0.360 |
Why?
|
Pseudomonas aeruginosa | 1 | 2015 | 1276 | 0.290 |
Why?
|
Carcinoma, Pancreatic Ductal | 4 | 2024 | 1758 | 0.290 |
Why?
|
Cystic Fibrosis | 1 | 2015 | 1287 | 0.260 |
Why?
|
Acrylic Resins | 2 | 2015 | 131 | 0.230 |
Why?
|
Polyethyleneimine | 2 | 2015 | 70 | 0.230 |
Why?
|
Inhibitor of Apoptosis Proteins | 2 | 2023 | 202 | 0.220 |
Why?
|
Irritable Mood | 1 | 2024 | 196 | 0.210 |
Why?
|
Electrocardiography | 1 | 2015 | 6404 | 0.200 |
Why?
|
Appendicitis | 2 | 2017 | 679 | 0.170 |
Why?
|
NF-kappa B | 3 | 2024 | 2485 | 0.170 |
Why?
|
Sinus Thrombosis, Intracranial | 1 | 2021 | 109 | 0.170 |
Why?
|
Phagocytes | 1 | 2021 | 292 | 0.160 |
Why?
|
Polyethylene Glycols | 2 | 2015 | 1188 | 0.160 |
Why?
|
Hemoglobins | 2 | 2015 | 1530 | 0.150 |
Why?
|
Interleukin-1beta | 1 | 2024 | 1028 | 0.150 |
Why?
|
Eosinophilic Esophagitis | 1 | 2021 | 206 | 0.150 |
Why?
|
Cyclin-Dependent Kinase 6 | 1 | 2021 | 352 | 0.150 |
Why?
|
Mucoproteins | 1 | 2017 | 49 | 0.140 |
Why?
|
Interferon-gamma | 2 | 2023 | 3160 | 0.140 |
Why?
|
Vaccination | 4 | 2023 | 3426 | 0.140 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2021 | 561 | 0.140 |
Why?
|
Liver Diseases | 1 | 2024 | 1303 | 0.130 |
Why?
|
Myocarditis | 1 | 2023 | 802 | 0.120 |
Why?
|
Electrochemical Techniques | 1 | 2015 | 90 | 0.120 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2021 | 1365 | 0.120 |
Why?
|
Databases, Genetic | 1 | 2021 | 1751 | 0.110 |
Why?
|
Vaccines | 1 | 2023 | 841 | 0.110 |
Why?
|
Abdominal Pain | 2 | 2017 | 1069 | 0.110 |
Why?
|
Biocatalysis | 1 | 2014 | 167 | 0.110 |
Why?
|
Natural Language Processing | 1 | 2021 | 1203 | 0.100 |
Why?
|
Ultrasonography | 3 | 2024 | 5993 | 0.090 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2536 | 0.080 |
Why?
|
Wheat Hypersensitivity | 1 | 2009 | 11 | 0.080 |
Why?
|
Biosensing Techniques | 1 | 2015 | 642 | 0.080 |
Why?
|
CD8-Positive T-Lymphocytes | 4 | 2024 | 4642 | 0.080 |
Why?
|
Temperature | 1 | 2015 | 2226 | 0.080 |
Why?
|
Peanut Hypersensitivity | 1 | 2011 | 217 | 0.080 |
Why?
|
Immunoglobulin E | 2 | 2011 | 1481 | 0.070 |
Why?
|
Aminopyridines | 2 | 2023 | 576 | 0.070 |
Why?
|
T-Lymphocytes | 2 | 2023 | 10261 | 0.070 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2024 | 11868 | 0.070 |
Why?
|
Tumor Microenvironment | 3 | 2024 | 3946 | 0.070 |
Why?
|
Paclitaxel | 2 | 2024 | 1728 | 0.070 |
Why?
|
Adenocarcinoma | 1 | 2023 | 6364 | 0.060 |
Why?
|
Infant | 6 | 2024 | 36385 | 0.060 |
Why?
|
Immunotherapy | 1 | 2021 | 4752 | 0.060 |
Why?
|
Protein Kinase Inhibitors | 1 | 2021 | 5696 | 0.060 |
Why?
|
Melanoma | 1 | 2023 | 5719 | 0.060 |
Why?
|
Humans | 25 | 2024 | 765956 | 0.060 |
Why?
|
Transforming Growth Factors | 1 | 2023 | 76 | 0.050 |
Why?
|
Diagnostic Imaging | 1 | 2017 | 3529 | 0.050 |
Why?
|
Neoplasms | 2 | 2023 | 22340 | 0.050 |
Why?
|
United States Food and Drug Administration | 2 | 2021 | 1672 | 0.050 |
Why?
|
Mice | 7 | 2023 | 81818 | 0.050 |
Why?
|
Perforin | 1 | 2023 | 166 | 0.050 |
Why?
|
Proteins | 1 | 2017 | 5995 | 0.050 |
Why?
|
Retrospective Studies | 9 | 2023 | 81515 | 0.050 |
Why?
|
Child, Preschool | 5 | 2017 | 42500 | 0.050 |
Why?
|
Adolescent | 7 | 2023 | 88832 | 0.050 |
Why?
|
Hospitalization | 1 | 2021 | 10808 | 0.050 |
Why?
|
Male | 13 | 2024 | 363691 | 0.040 |
Why?
|
Electronic Health Records | 3 | 2023 | 4873 | 0.040 |
Why?
|
Albumins | 1 | 2023 | 577 | 0.040 |
Why?
|
Interleukin-12 | 1 | 2023 | 579 | 0.040 |
Why?
|
Enteritis | 1 | 2021 | 163 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2023 | 13648 | 0.040 |
Why?
|
Drug Evaluation | 1 | 2021 | 641 | 0.040 |
Why?
|
Mass Vaccination | 1 | 2021 | 111 | 0.040 |
Why?
|
Deoxycytidine | 1 | 2024 | 889 | 0.040 |
Why?
|
Gastritis | 1 | 2021 | 200 | 0.040 |
Why?
|
Child | 6 | 2023 | 80563 | 0.040 |
Why?
|
Purines | 1 | 2023 | 615 | 0.040 |
Why?
|
Vaccines, Synthetic | 1 | 2022 | 621 | 0.040 |
Why?
|
Breast Neoplasms, Male | 1 | 2021 | 212 | 0.040 |
Why?
|
Animals | 8 | 2023 | 168759 | 0.040 |
Why?
|
Molecular Sequence Annotation | 1 | 2021 | 523 | 0.040 |
Why?
|
United States | 6 | 2023 | 72898 | 0.040 |
Why?
|
Abdomen | 1 | 2024 | 1134 | 0.040 |
Why?
|
Young Adult | 4 | 2021 | 59886 | 0.040 |
Why?
|
Sequence Deletion | 1 | 2023 | 1495 | 0.040 |
Why?
|
Infant, Newborn | 2 | 2015 | 26349 | 0.040 |
Why?
|
Ornithine | 1 | 2017 | 80 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 2 | 2017 | 20660 | 0.030 |
Why?
|
Anti-Bacterial Agents | 1 | 2015 | 7478 | 0.030 |
Why?
|
Immunity | 1 | 2023 | 1002 | 0.030 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2021 | 878 | 0.030 |
Why?
|
Eosinophilia | 1 | 2021 | 556 | 0.030 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2024 | 1801 | 0.030 |
Why?
|
RNA, Messenger | 2 | 2022 | 12769 | 0.030 |
Why?
|
Follow-Up Studies | 2 | 2015 | 39194 | 0.030 |
Why?
|
Eosinophils | 1 | 2021 | 945 | 0.030 |
Why?
|
Organ Specificity | 1 | 2021 | 1965 | 0.030 |
Why?
|
Female | 10 | 2024 | 396101 | 0.030 |
Why?
|
Elements | 1 | 2015 | 20 | 0.030 |
Why?
|
Benzimidazoles | 1 | 2021 | 864 | 0.030 |
Why?
|
Steam | 1 | 2015 | 34 | 0.030 |
Why?
|
Electrophoresis, Agar Gel | 1 | 2015 | 204 | 0.030 |
Why?
|
Cell Line, Tumor | 2 | 2023 | 17075 | 0.030 |
Why?
|
Protein Denaturation | 1 | 2015 | 240 | 0.030 |
Why?
|
Transforming Growth Factor beta | 1 | 2023 | 1995 | 0.030 |
Why?
|
Obesity | 1 | 2017 | 13075 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2024 | 2570 | 0.030 |
Why?
|
Sterilization | 1 | 2015 | 133 | 0.030 |
Why?
|
Hospitals, Community | 1 | 2017 | 363 | 0.030 |
Why?
|
Time Factors | 3 | 2021 | 40065 | 0.030 |
Why?
|
Neoplasm Metastasis | 1 | 2024 | 4893 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2021 | 21056 | 0.030 |
Why?
|
Propensity Score | 1 | 2021 | 1968 | 0.030 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2015 | 684 | 0.030 |
Why?
|
Arginine | 1 | 2017 | 933 | 0.030 |
Why?
|
Oncogene Proteins | 1 | 2017 | 710 | 0.030 |
Why?
|
Electrodes | 1 | 2015 | 609 | 0.030 |
Why?
|
Incidence | 2 | 2021 | 21480 | 0.030 |
Why?
|
Aged | 5 | 2024 | 171114 | 0.030 |
Why?
|
Radiology Information Systems | 1 | 2017 | 532 | 0.020 |
Why?
|
Peroxidase | 1 | 2015 | 606 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2023 | 2895 | 0.020 |
Why?
|
Hydrogen Peroxide | 1 | 2015 | 743 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2021 | 6832 | 0.020 |
Why?
|
Prospective Studies | 1 | 2015 | 54806 | 0.020 |
Why?
|
Piperazines | 1 | 2021 | 2549 | 0.020 |
Why?
|
Cattle | 1 | 2015 | 3801 | 0.020 |
Why?
|
Hospitals | 1 | 2023 | 3888 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2021 | 15880 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2024 | 12976 | 0.020 |
Why?
|
Pyridines | 1 | 2021 | 2888 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2021 | 3800 | 0.020 |
Why?
|
Kinetics | 1 | 2015 | 6274 | 0.020 |
Why?
|
Middle Aged | 4 | 2024 | 223004 | 0.020 |
Why?
|
Emergency Service, Hospital | 2 | 2017 | 7875 | 0.020 |
Why?
|
Survival Rate | 1 | 2021 | 12795 | 0.020 |
Why?
|
Apoptosis | 1 | 2023 | 9514 | 0.020 |
Why?
|
Cohort Studies | 2 | 2022 | 41647 | 0.020 |
Why?
|
Cytokines | 1 | 2021 | 7421 | 0.020 |
Why?
|
Macrophages | 1 | 2021 | 5772 | 0.020 |
Why?
|
Hypersensitivity, Immediate | 1 | 2009 | 346 | 0.020 |
Why?
|
Age of Onset | 1 | 2011 | 3343 | 0.010 |
Why?
|
Risk Factors | 2 | 2021 | 74836 | 0.010 |
Why?
|
Allergens | 1 | 2011 | 1436 | 0.010 |
Why?
|
Mitochondria | 1 | 2017 | 3673 | 0.010 |
Why?
|
Food Hypersensitivity | 1 | 2011 | 737 | 0.010 |
Why?
|
Adult | 3 | 2021 | 223038 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2021 | 22331 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2017 | 14447 | 0.010 |
Why?
|
Pandemics | 1 | 2021 | 8701 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2017 | 8611 | 0.010 |
Why?
|
Immune Tolerance | 1 | 2009 | 2324 | 0.010 |
Why?
|
Risk Assessment | 1 | 2021 | 24283 | 0.010 |
Why?
|
Mutation | 1 | 2023 | 30196 | 0.010 |
Why?
|
Signal Transduction | 1 | 2021 | 23600 | 0.010 |
Why?
|
Environmental Exposure | 1 | 2011 | 4543 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2011 | 14749 | 0.010 |
Why?
|
Age Factors | 1 | 2009 | 18380 | 0.010 |
Why?
|
Prognosis | 1 | 2009 | 29921 | 0.000 |
Why?
|
Concepts
(158)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(42)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_